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Limb-salvage angioplasty in vascular surgery
practice
Girma Tefera, MD, John Hoch, MD, and William D. Turnipseed, MD, Madison, Wis
Objective:To assess outcomes of percutaneous infrainguinal arterial angioplasty for treatment of chronic limb-threatening
ischemia (CLI) in poor surgical candidates.
Methods: A retrospective clinical analysis of 67 consecutively treated patients (76 limbs) with CLI over a 33-month period
was performed. Patients were considered poor surgical candidates because of absent distal target vessels (31 limbs), severe
comorbid conditions (36 limbs), or lack of an autologous vein for distal bypass (9 limbs). Limb salvage was defined as
preservation of a functional foot without the need for a prosthesis. Technical success was defined as the ability to
percutaneously recanalize the arterial segment with less than 30% residual stenosis. Clinical success was healing of ulcers
or minor amputation sites, resolving rest pain, or avoiding a major amputation. Successful technical and clinical outcomes
were correlated with patient demographics, clinical presentation, and TransAtlantic Inter-Society Consensus arterial
lesion characteristics by using the Fisher exact test.
Results: Seventy-six limbs were treated for rest pain (n  12), gangrene (n  22), or nonhealing ulcers (n  42). There
were 40 men and 27 women. The mean age was 70 years (range, 36-94 years). Lesions were located in tibial (n  55),
popliteal (n  6), and superficial femoral (n  15) arteries. Arterial recanalization and limb salvage was achieved in 64
(83.5%) limbs. Technical failure (n 12) correlated with TransAtlantic Inter-Society Consensus D lesions (P .009) and
the presence of occlusion (P .027). Clinical failure (major amputation, n 12) correlated with the presence of gangrene
(P  .032) or the combination of diabetes, arterial occlusion, and gangrene (P  .018). The single variables of age, sex,
diabetes, and renal failure did not adversely affect outcomes. There was one mortality (myocardial infarction), and there
were two major morbidities (femoral artery pseudoaneurysm and sepsis).
Conclusions: Peripheral arterial angioplasty should be considered as an alternative to primary amputation in selected
patients with CLI who are poor candidates for traditional surgical bypass. ( J Vasc Surg 2005;41:988-93.)Lower extremity bypass surgery is the gold standard for
treatment of chronic critical limb ischemia (CLI).1,2 In recent
years, despite a lack of level I clinical evidence to support it,
there has been renewed interest in catheter-based treatment of
lower extremity arterial occlusive diseases. This current enthu-
siasm is partly due to the substantial advances made in guide-
wire, balloon, and stent technology, as well as the availability
of new antiplatelet drugs. Although vascular surgeons may be
less enthusiastic than other vascular specialists (interventional
cardiologists and radiologists), the use of percutaneous treat-
ments for CLI is becoming more common. Low morbidity
and mortality rates make percutaneous procedures attractive,
although durable patency remains an issue.3-5 At our institu-
tion, limb-salvage angioplasty has been introduced as an alter-
native to primary amputation in selected poor surgical candi-
dates with end-stage arterial occlusive disease. The purpose of
this study was to evaluate the treatment outcomes after limb-
salvage angioplasty for patients who otherwise would be can-
didates for primary amputation.
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988MATERIALS AND METHODS
This study was a retrospective clinical analysis of 67
consecutive poor-surgical-risk patients treated with percu-
taneous transluminal angioplasty (PTA) of the infraingui-
nal vessels for limb-threatening ischemia (76 limbs) over 33
months (January 2001 to November 2003). Patients were
considered poor bypass operation candidates on the basis of
the absence of an adequate greater saphenous vein for distal
bypass, the presence of a poor distal bypass target vessel, or
the presence of severe comorbid conditions. These comor-
bid conditions included recent myocardial infarction (6
weeks), symptomatic coronary artery disease, renal insuffi-
ciency (creatinine level 2 mg/dL or dialysis dependent),
or severe chronic obstructive pulmonary disease. No pa-
tient was excluded on the basis of the extent of arterial
occlusive disease. Primary amputations was performed if
patients were septic or had significant amount of soft tissue
loss in the foot that might preclude foot salvage. Good-
surgical-risk patients were offered infrainguinal arterial by-
pass.
Limb salvage was defined as preservation of a functional
foot without the need for a leg prosthesis. Clinical success
was defined as resolving rest pain, healing of an ulcer or toe
amputation site, or avoiding major amputation (below-
knee amputation or above-the-knee amputation). Prepro-
cedure and postprocedure ankle-brachial indices (ABIs)
were used to evaluate hemodynamic improvement. An
increase in ABI greater than 0.10 was considered signifi-
cant. Duplex ultrasound study was used to follow up on
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defined as arterial recanalization with less than 30% residual
stenosis. Patients’ demographic data, their indications for
intervention, the location and morphologic classification of
the lesions treated, and the morbidity and mortality associ-
ated with the procedure were analyzed on the basis of the
reporting standards recommended by the Society for Vas-
cular Surgery-International Society for Cardiovascular Sur-
gery Ad Hoc Committee.6 High-grade stenosis was defined
as stenosis of greater than 50% detected by visual estima-
tion. Technical success was defined as arterial recanalization
with less than 30% stenosis by visual estimation. Morpho-
logic classification of arterial lesions was based on the
TransAtlantic Inter-Society Consensus (TASC) defini-
tions.7 All patients were evaluated and underwent angio-
plasty by vascular surgeons from the section of vascular
surgery at the University of Wisconsin. According to the
morphologic appearance, the adequacy of the distal target
artery was determined by the treating vascular surgeon.
Postprocedure follow-up was scheduled at 1, 3, and 6
months and yearly thereafter. SAS software (SAS Institute,
Cary, NC) was used for statistical analysis, and the Fisher
exact test was used to evaluate significance (P  .05).
Angioplasty procedures were performed with patients
under local anesthesia and intravenous sedation in a dedi-
cated angiography suite equipped with a variable 8- to
15-inch image intensifier.Magnetic resonance angiography
was used as previously described for open surgical revascu-
larization as a preprocedural diagnostic tool to define the
location of lesions and plan catheter access.8 All patients
were started on clopidogrel bisulfate 75 mg daily 3 days
before the procedure or 300mg the day of the procedure in
addition to acetylsalicylic acid (81-325 mg). Heparin anti-
coagulation to obtain an activated clotting time longer than
250 seconds was used in all patients before the lesions were
crossed. Only high-grade stenoses or total occlusions were
treated. Ipsilateral antegrade common femoral access was
preferentially used (85%). An angled 0.035-inch Terumo
Glidewire (Meditech, Natick, Mass) was used to create a
subintimal dissection in occluded superficial femoral or
popliteal arteries. This wire was allowed to form a loop at
the tip and was advanced in conjunction with a multipur-
pose catheter or an angioplasty balloon catheter until the
arterial lumen was entered distal to the occlusion. For
infrapopliteal occlusive lesions, a low-profile (0.014 inch)
coronary guidewire—Choice PT (Boston Scientific, Maple
Grove, Minn), Hi_Torque Traverse (Guidant Corp, Santa
Clara, Calif), or Cross-it 200 (Guidant Corp)—was sup-
ported with a Maverick balloon (Boston Scientific) and
used to cross the lesions. Once occlusive lesions were
crossed, the guidewire was removed, and angiography was
performed through the catheter to confirm the distal in-
traluminal position. Balloon angioplasties were performed
by using 4- to 6-mm-diameter balloons in the superficial
femoral and popliteal arteries and by using 2- to 3.5-mm-
diameter by 2- to 10-cm-long low-profile SAVY balloons
(Cordis, Warren, NJ) in the tibial vessels. Balloon inflation
times varied from 15 to 60 seconds at 8 to 12 atm. Localarterial dissections were usually treated with prolonged
low-atmosphere balloon inflations without stenting.
RESULTS
Over 33 months, 76 limbs in 67 consecutive patients
were percutaneously treated for CLI. During the same
period, 150 patients underwent infrainguinal bypass oper-
ations, and 110 patients had primary amputations. The
mean age was 70.5 years (range, 36-94 years). There were
40 male patients and 27 female patients. Patient demo-
graphics and comorbid conditions are listed in Table I. The
median length of hospital stay was 1 day, and the average
follow-up time was 8.8 months (range, 1-33 months).
Indications for treatment included nonhealing ulcers in
42 limbs, gangrenous digits in 22 limbs, and rest pain in 12
limbs. All patients were in Rutherford clinical category6 4
or 5 (Table II). None of these patients had had a previous
bypass operation. The TASC morphologic classification of
the treated lesions was as follows: A, n 8; B, n 15; C, n
 18; and D, n  35. There were 40 total occlusions and
36 stenoses. Treated lesions were in the tibial arteries in 55
limbs, the popliteal artery in 6 limbs, and the superficial
femoral artery in 15 limbs (Table III). Multilevel angioplas-
ties were performed in 18 limbs. Patients qualified as poor
risk for bypass surgery on the basis of a lack of a distal target
vessel in 31 limbs, severe comorbid conditions in 36 pa-
tients (recent myocardial infarction in 12, renal insuffi-
ciency in 27, and dialysis dependence in 12), and lack of an
autologous vein (greater saphenous vein) for distal bypass
in 9 limbs.
On the basis of intention to treat, technical success was
achieved in 64 limbs (83.5%). All technical failures were
due to an inability to cross the lesions. No stents were used.
Of the 12 technical failures, 6 limbs were bypassed, 4
required primary amputation, and 2 patients refused any
further therapy. Of these two, one had ArtAssist (ACI
Medical) pneumatic compression, and the ulcer healed; the
other patient died a few months later. Of the six patients
who underwent revascularization, two have died, two un-
derwent below-the-knee amputation, and two are alive
with intact limbs. Technical failures were correlated with
TASC D lesions (P .009) and the presence of a complete
occlusion (P  .027).
The limb-salvage rate was 83.5%. There were 12 major
Table I. Demographics
Variable Data
Mean age (y) 70.5
Male:female 40:27
Diabetes 70%
Coronary artery disease 71%
Renal failure 36%
Hypertension 55%
Contralateral leg amputation 17%
Kidney transplantation 9%amputations. Limb loss occurred in four patients after
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successful angioplasty. Limb loss was due to infection in
four patients (despite initial clinical improvement), recur-
rent disease in two, and lack of clinical improvement in two.
Major amputation correlated with the clinical presence of
digital gangrene (P .032) or the combination of diabetes,
arterial occlusion, and gangrene (P  .018). The presence
or absence of diabetes or renal failure alone did not signif-
icantly affect technical failure or limb loss. The presence of
renal failure showed a trend toward significance in limb loss
(P .08). All patients with rest pain had resolution of their
symptoms after angioplasty. Seventy-three percent of toe
amputation sites healed primarily. Age, sex, history of dia-
betes, and renal failure did not adversely affect clinical or
technical outcomes.
During follow-up, the recurrence of clinical symptoms
(clinical recurrence) correlated with recurrent arterial ste-
nosis in four patients. In two patients (50%), repeat percu-
taneous treatment was successful, whereas in the other two,
the inability to perform repeat PTA led to a major amputa-
tion. Both of these patients had recurrent tibial occlusive
disease. All recurrences, as well as clinical failures that led to
major amputation, occurred within 6 months of primary
angioplasty. Noninvasive vascular testing with serial ABI
measurements for follow-up of these patients was useful in
only 50% of the cases, because the other half had noncom-
pressible vessels. There was a significant increase in ABI
after successful angioplasty. In patients with compressible
Table II. Outcome by clinical presentation
Variable
No.
limbs
Technical
failure
Major
amputation
Gangrene 22 13% 31%*
Ulcer 41 22.5% 12%
Rest pain 13 0 0
*P  .32.
Table III. Outcome by lesion location and morphology
Variable
No.
limbs
Technical
failure rate
Major
amputation rate
Occlusion 40 25%* 17.5%
Stenosis 36 5.5% 13.8%
Location of lesion
SFA 16 6.25% 6.25%
Popliteal 3 33.3% 0
Tibial 57 17.5 19.3
TASC classification
A 8 0 12.5
B 15 0 13.3
C 18 11% 11.1%
D 35 28%† 20%
SFA, Superficial femoral artery; TASC, TransAtlantic Inter-Society Consen-
sus.
*P  .027.
†P  .009.vessels, ABI increased from a preprocedure mean of 0.54 toa postprocedure mean of 0.83 (mean increase by 0.29;
range, 0.1-0.62). Duplex ultrasound evaluation of the su-
perficial femoral artery was routinely performed.
There was one (1.5%) perioperative death due to myo-
cardial infarction, and there were two (3%) major morbid-
ities. A femoral artery puncture site pseudoaneurysm was
treated with ultrasound-guided thrombin injection, and
one patient developed sepsis after successful thrombolysis
of a tibial artery PTA site. Images in Figs 1 to 6 illustrate a
case of CLI with multilevel disease treated percutaneously.
DISCUSSION
Up to 40% of extremities with ischemic nonhealing
ulcers, gangrenous digits, or rest pain may require a major
amputation within 6 months of onset unless successfully
revascularized.9 Infrainguinal lower extremity bypass sur-
gery for limb salvage is the gold standard treatment for
these conditions. However, surgical bypass may not be a
Fig 1. Ischemic foot with digital gangrene.
Fig 2. Eighteen months after percutaneous transluminal
angioplasty.good option for patients with limited life expectancy, poor
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nous conduit, or significant comorbid conditions. Al-
though there is a role for primary amputation in patients
who are poor candidates for surgical revascularization, the
morbidity and mortality associated with major amputation
remain high.10,11 Therefore, alternative treatment for pa-
tients with limb-threatening ischemia should be considered
whenever arterial bypass is not possible or is hazardous. In
the 1980s, studies on vasoactive drugs as an alternative
treatment for CLI were unsuccessful.9,12 Early experience
with PTA for limb salvage was poor.13,14
In recent years, because of improved competency and
experience of vascular specialists, as well as the advances
made in catheter and guidewire technology, catheter-based
treatment of lower extremity arterial occlusive disease has
shown significantly improved limb-salvage outcomes. Al-
Fig 3. Superficial femoral artery occlusion.though to date there is no level I evidence that defines therole of infrainguinal arterial angioplasty for limb salvage as
compared with bypass surgery, a few retrospective studies
have addressed this issue. Blair et al15 reported comparable
limb-salvage rates with PTA and bypass surgery in the
treatment of limb-threatening ischemia—78% vs 81%, re-
spectively, at 2 years—despite a very low patency rate in the
PTA group. Contemporary reports on PTA suggest that
high technical and clinical success rates are possible.3-5
Some authors recommend that infrainguinal PTA be of-
fered as the first line of treatment in most patients with
CLI.16,17 This idea is supported by Dorros et al,18 who
achieved a technical success rate of 94% and a limb-salvage
rate of 91% at 5 years. Although this exceptionally high
success rate has not been reproduced by many other inves-
tigators, technical and limb-salvage rates of 70% to 80% at 1
to 2 years are not uncommon.5,16,19 At the University of
Wisconsin, we have used infrainguinal arterial angioplasty
as part of our endovascular program for treatment of limb-
threatening ischemia since 2001. This treatment option is
offered to patients considered high risk or poor candidates
Fig 4. After percutaneous revascularization.for surgical bypass. We hypothesized that infrainguinal
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improved limb-salvage rate with lowmorbidity and mortal-
ity when compared with primary amputation in patients
who are considered poor surgical candidates.
Our technical and clinical success rate was 83.5% each,
which is similar to that reported in the literature. Technical
failures were due to an inability to cross the lesions with
guidewires. Not surprisingly, technical failure correlated
with the worst lesion morphology (TASC D), and clinical
failure correlated with the worst clinical presentation (gan-
grenous digits). One third of the patients in our series who
presented with gangrenous digits required a major ampu-
tation, and this was significantly more than those who
presented with rest pain only (0%) or ulcer (12.5%). This is
not significantly different from the 60% limb salvage
achieved l year after bypass operation in the presence of
established forefoot gangrene.20
In the literature, the reported morbidity and mortality
rate associated with percutaneous arterial revascularization
seems low.3,19 In this series, the morbidity and mortality
rates were 3% and 1.5%, respectively. Goshima et al21
Fig 5. Tibial occlusive disease.reported that infrainguinal bypass surgery is often compli-cated by prolonged recovery, multiple reoperations (up to
48.9%), and multiple readmissions (49.3%). Moreover, ac-
cording to Baldwin et al,22 if reoperations were due to early
graft failure (30 days), then limb-salvage rates were as low
as 25%. On the basis of these unfavorable surgical bypass
results, some authors recommend a percutaneous attempt
as the initial treatment for patients with CLI. This recom-
mendation is also supported by the fact that failed PTA
does not negatively affect future surgical bypass.4,15 Others
recommend PTA in CLI only in patients considered to be
high risk for bypass surgery.13,14 According to our results,
patients with stenoses or TASCA and B lesions, irrespective
of their comorbid conditions, should be considered for
percutaneous treatment, whereas patients with TASC D
lesions in the tibial vessels may benefit from percutaneous
treatment only if they are poor surgical candidates.
During follow-up, of the four recurrent lesions, repeat
PTA failed in two, and this ultimately led to limb loss. In a
report by Faglia et al,3 of 14 patients with recurrent lesions,
10 (71%) responded to a repeat angioplasty. We have found
that close follow-up, particularly in the first year, is the key
to successful outcomes, because all failures in our series
occurred within the first 6 months of treatment. This
follow-up is primarily clinical and evaluates ulcer healing,
resolution of rest pain, or healing of the amputation site.
Fig 6. After tibial angioplasty.This is similar to reports by Gordon et al,23 in which there
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occurred by 6 to 12 months. In addition to clinical follow-
up, we found that ABI measurements can be reliable in up
to 50% of patients.
One unanswered question regards the effect of stents
on long-term patency. Drug-eluting stents seem promising
in the coronary circulation but have yet failed to show
improved outcomes in peripheral arteries.24 In our series,
stents were not used. Whenever extensive local dissections
were encountered after PTA, prolonged balloon inflations
were usually effective. Our decision not to use stents was
based on the poor results reported in the literature.25,26
This was a retrospective study with a relatively small
number of patients and short-term follow-up. These results
may not apply to low-surgical-risk patients with CLI. Our
study suggests a need for a randomized clinical trial be-
tween PTA and bypass surgery.
CONCLUSION
This study does indicate that limb-salvage angioplasty
can be successfully achieved with low morbidity and mor-
tality rates in high-risk or poor-surgical-risk patients. The
limb-salvage rate was 83.5% in a group of patients destined
for major amputation. Patients with gangrenous digits were
more likely to require a major amputation. Age, diabetes,
and renal insufficiency did not independently affect clinical
outcomes. Vascular surgeons should consider limb-salvage
angioplasty before performing primary major amputation
in patients who are unfit for bypass surgery.
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